Poly Medicure Ltd

Poly Medicure Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Poly Medicure Ltd

₹ 2,048 -1.25%
22 Jul 4:01 p.m.
polymedicure.com BSE: 531768 NSE: POLYMED
About

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]

Key Points

Product Portfolio
It is a medical devices company with product portfolio comprises of more than 130 SKUs of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. [1]

Website BSE NSE
  • Market Cap ₹ 19,655 Cr.
  • Current Price ₹ 2,048
  • High / Low ₹ 2,237 / 1,115
  • Stock P/E 74.6
  • Book Value ₹ 152
  • Dividend Yield 0.15 %
  • ROCE 23.1 %
  • ROE 18.7 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has delivered good profit growth of 30.9% CAGR over last 5 years
  • Promoter holding has increased by 12.9% over last quarter.

Cons

  • Stock is trading at 13.5 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
203 212 220 244 239 264 272 293 306 320 321 361 367
149 161 169 188 191 198 203 212 220 237 236 264 266
Operating Profit 54 50 51 57 48 66 68 82 85 83 84 97 101
OPM % 27% 24% 23% 23% 20% 25% 25% 28% 28% 26% 26% 27% 28%
10 12 7 9 5 9 14 9 13 13 17 16 17
Interest 3 0 -1 1 1 0 5 2 2 2 3 3 3
Depreciation 13 13 13 14 14 14 14 15 15 15 16 16 19
Profit before tax 49 50 46 51 38 61 64 73 81 78 82 94 96
Tax % 26% 25% 25% 25% 24% 26% 26% 22% 25% 24% 25% 25% 25%
36 37 34 38 29 45 48 57 61 59 61 71 72
EPS in Rs 3.76 3.89 3.57 4.01 3.00 4.71 4.96 5.99 6.31 6.17 6.41 7.35 7.53
Raw PDF
Upcoming result date: today

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
252 312 373 393 439 507 586 646 746 879 1,068 1,307 1,369
199 238 288 307 345 386 452 483 536 665 797 958 1,003
Operating Profit 52 74 85 86 94 122 134 162 210 214 270 350 366
OPM % 21% 24% 23% 22% 21% 24% 23% 25% 28% 24% 25% 27% 27%
0 11 28 8 13 14 16 19 19 39 32 58 62
Interest 7 9 10 10 8 11 13 20 10 5 10 11 11
Depreciation 12 14 18 20 23 28 36 39 46 53 56 62 66
Profit before tax 34 62 84 65 76 96 100 122 173 195 237 335 350
Tax % 29% 31% 27% 27% 26% 27% 34% 24% 25% 25% 24% 25%
24 43 61 47 56 70 66 92 130 146 179 252 264
EPS in Rs 2.73 4.88 6.92 5.36 6.37 7.96 7.51 10.47 13.51 15.23 18.66 26.23 27.46
Dividend Payout % 9% 20% 18% 28% 39% 25% 27% 19% 19% 16% 16% 11%
Compounded Sales Growth
10 Years: 15%
5 Years: 17%
3 Years: 21%
TTM: 21%
Compounded Profit Growth
10 Years: 21%
5 Years: 31%
3 Years: 25%
TTM: 25%
Stock Price CAGR
10 Years: 33%
5 Years: 64%
3 Years: 27%
1 Year: 81%
Return on Equity
10 Years: 18%
5 Years: 17%
3 Years: 16%
Last Year: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 11 22 22 22 44 44 44 44 48 48 48 48
Reserves 100 122 170 202 225 290 336 385 906 1,029 1,186 1,410
49 67 76 79 97 127 150 194 126 111 137 165
52 71 87 73 83 93 103 117 107 146 167 199
Total Liabilities 212 282 354 376 449 555 633 740 1,187 1,334 1,538 1,821
89 120 161 177 201 260 272 328 389 451 598 835
CWIP 8 20 10 14 20 18 19 25 21 43 78 67
Investments 7 6 6 6 6 18 42 58 385 384 176 221
108 137 178 180 222 258 300 330 392 456 686 699
Total Assets 212 282 354 376 449 555 633 740 1,187 1,334 1,538 1,821

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
38 65 63 62 55 76 113 127 116 126 195 256
-30 -58 -57 -30 -54 -87 -104 -106 -434 -89 -187 -237
-8 6 -9 -31 -1 14 -10 -22 319 -40 -8 -17
Net Cash Flow 0 13 -2 1 0 3 -1 -1 1 -2 -0 2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 61 53 58 75 79 81 77 68 73 80 76 72
Inventory Days 144 140 146 105 193 207 138 241 202 210 222 156
Days Payable 100 102 103 77 136 130 93 144 104 109 95 72
Cash Conversion Cycle 105 91 101 103 136 157 123 165 171 181 203 156
Working Capital Days 55 31 42 64 82 93 80 70 104 113 108 136
ROCE % 27% 33% 30% 26% 25% 26% 23% 25% 21% 16% 19% 23%

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
44.77% 44.76% 44.66% 53.34% 53.33% 53.33% 53.32% 53.32% 53.17% 53.17% 53.14% 66.02%
13.68% 14.13% 15.07% 15.59% 16.27% 16.33% 16.21% 15.61% 14.49% 14.10% 12.37% 9.91%
2.87% 2.99% 3.33% 3.25% 3.39% 3.38% 3.67% 4.25% 5.15% 5.46% 7.21% 9.34%
38.68% 38.11% 36.94% 27.82% 27.02% 26.97% 26.79% 26.82% 27.20% 27.28% 27.25% 14.72%
No. of Shareholders 33,67835,16633,83133,29634,23932,01535,39336,14134,64936,05336,71236,852

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls